A living evidence approach treats evidence as shared infrastructure rather than as a series of isolated projects.

ACA Pharma: team@acapharma.net Azurity Pharmaceuticals: media@azurity.com ...

The U.S. is the biggest single market for most pharma and biotech firms. Among the 10 largest biopharmaceutical companies in the Stoxx 600 health index, five get a majority of their total sales from ...

BeOne Medicines is monetizing its stake in Amgen’s first-in-class lung cancer drug Imdelltra for up to $950 million. Royalty Pharma will pay BeOne $885 million upfront for certain royalty payments ...

Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...

As the trend of direct-to-consumer (DTC) platforms continues to grow, pharma marketers are beginning to devise marketing strategies around them involving brand and above-brand strategies, patient ...

As advances in artificial intelligence technology continue to offer enticing benefits to industries across the board, pharma leaders aren't looking to miss out on implementing the technology into ...

President Trump has announced today he plans to reduce U.S. drug prices by 30-80% via an Executive Order, targeting Big Pharma's high costs and profits. U.S. drug prices are significantly higher (up ...

Olivia Goldhill focused primarily on covering the health crisis affecting American boys and men. She also covered psychedelic medicines. AbbVie’s purchase of Gilgamesh Pharmaceuticals’ psychedelic ...

US drugmakers' shares drop 3% to 6% premarket European, Indian healthcare stocks drag down broader indexes Trump aims to shift pharma manufacturing to US, but analysts doubtful April 9 (Reuters) - ...

Business: Verona Pharma, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The ...

In a wildly chaotic quarter, one thing has remained stable—industry layoffs. Biopharmas recorded 62 layoff rounds, just a smidge lower than the 64 reported both in the first and second quarter each, ...